More recently, a role for pathogenetic polymorphisms in PAH-CHD has been suggested: BMPR2 mutations were identified in 6% of adults and children with PAH-CHD (mainly Eisenmenger syndrome or post-repair), although the role of BMPR2 in PAH-CHD remains unclear (17). This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.